Dodge & Cox Incyte Corp Put Options Transaction History
Dodge & Cox
- $160 Billion
- Q4 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding INCY
# of Institutions
703Shares Held
189MCall Options Held
909KPut Options Held
447K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.19 Billion23.54% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.52 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.4 Billion0.02% of portfolio
-
State Street Corp Boston, MA10MShares$715 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.09MShares$291 Million0.45% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.9B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...